$DRIO
DarioHealth Corp. Stock $drio

$drio Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000114420414030461 Filed on May 14, 2014

Income Statement

Concept	2014 Q1	2013 Q1	2012
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$421.0K
YoY Change
Gross Profit	-$421.0K
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.140M	$2.010M	$2.040M
YoY Change	-43.28%	528.12%	1175.0%
% of Gross Profit
Research & Development	$1.107M	$675.0K	$1.501M
YoY Change	64.0%		1776.58%
% of Gross Profit
Depreciation & Amortization	$198.0K	$117.0K	$24.32K
YoY Change	69.23%
% of Gross Profit
Operating Expenses	$2.247M	$675.0K	$1.501M
YoY Change	232.89%	37.76%	552.72%
Operating Profit	-$2.668M	-$3.076M	-$3.974M
YoY Change	-13.26%
Interest Expense	$140.0K	-$2.150M	-$1.710M
YoY Change	-106.51%	2587.5%	-17200.0%
% of Operating Profit
Other Income/Expense, Net	-$316.0K	-$15.00K	-$1.712M
YoY Change	2006.67%		970.1%
Pretax Income	-$2.980M	-$5.230M	$2.988M
YoY Change	-43.02%	817.54%	-866.08%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$2.984M	-$5.227M	-$5.687M
YoY Change	-42.91%	816.99%	1358.21%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.14	-$0.35
Diluted Earnings Per Share	-$0.14	-$0.35	-$569.0M
COMMON SHARES
Basic Shares Outstanding	21.27B shares	14.81B shares
Diluted Shares Outstanding	21.42M shares	14.81M shares

Balance Sheet

Concept	2014 Q1	2013 Q1	2012
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.000M	$300.0K	$1.250M
YoY Change	1233.33%		35.87%
Cash & Equivalents	$3.812M	$294.0K	$1.230M
Short-Term Investments	$200.0K	$0.00	$20.00K
Other Short-Term Assets	$600.0K	$0.00	$410.0K
YoY Change			4000.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.600M	$700.0K	$1.670M
YoY Change	557.14%		79.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.100M	$1.300M	$620.0K
YoY Change	-15.38%		3000.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$30.00K
YoY Change			50.0%
Total Long-Term Assets	$1.100M	$1.400M	$650.0K
YoY Change	-21.43%		1200.0%
TOTAL ASSETS
Total Short-Term Assets	$4.600M	$700.0K	$1.670M
Total Long-Term Assets	$1.100M	$1.400M	$650.0K
Total Assets	$5.700M	$2.100M	$2.320M
YoY Change	171.43%		136.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$500.0K	$700.0K	$250.0K
YoY Change	-28.57%		733.33%
Accrued Expenses			$320.0K
YoY Change			255.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.217M	$1.200M	$570.0K
YoY Change	1.42%		375.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.800M	$5.000M	$2.820M
YoY Change	16.0%		327.27%
Total Long-Term Liabilities	$5.800M	$5.000M	$2.820M
YoY Change	16.0%		327.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.217M	$1.200M	$570.0K
Total Long-Term Liabilities	$5.800M	$5.000M	$2.820M
Total Liabilities	$7.000M	$6.100M	$3.380M
YoY Change	14.75%		327.85%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.300M	-$4.086M	-$1.070M
YoY Change
Total Liabilities & Shareholders Equity	$5.700M	$2.100M	$2.320M
YoY Change	171.43%		136.73%

Cashflow Statement

Concept	2014 Q1	2013 Q1	2012
OPERATING ACTIVITIES
Net Income	-$2.984M	-$5.227M	-$5.687M
YoY Change	-42.91%	816.99%	1358.21%
Depreciation, Depletion And Amortization	$198.0K	$117.0K	$24.32K
YoY Change	69.23%
Cash From Operating Activities	-$2.340M	-$970.0K	-$2.980M
YoY Change	141.24%	203.13%	2028.57%
INVESTING ACTIVITIES
Capital Expenditures	$116.0K	-$460.0K	$534.6K
YoY Change	-125.22%	4500.0%	-2773.17%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$30.00K
YoY Change			0.0%
Cash From Investing Activities	-$120.0K	-$460.0K	-$560.0K
YoY Change	-73.91%	4500.0%	833.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.000M	500.0K	3.870M
YoY Change	700.0%	-45.65%	251.82%
NET CHANGE
Cash From Operating Activities	-2.340M	-970.0K	-2.980M
Cash From Investing Activities	-120.0K	-460.0K	-560.0K
Cash From Financing Activities	4.000M	500.0K	3.870M
Net Change In Cash	1.540M	-930.0K	330.0K
YoY Change	-265.59%	-257.63%	-63.33%
FREE CASH FLOW
Cash From Operating Activities	-$2.340M	-$970.0K	-$2.980M
Capital Expenditures	$116.0K	-$460.0K	$534.6K
Free Cash Flow	-$2.456M	-$510.0K	-$3.515M
YoY Change	381.57%	64.52%	2828.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	539000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1217000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1089000	USD
CY2013Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	497000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3076000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2263000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	38000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	154000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	475000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2930000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	41000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1145000	USD
CY2013Q4	us-gaap	Assets Assets	4116000	USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	586000	USD
CY2014Q1	drio	Other Accounts Payable And Accrued Expenses OtherAccountsPayableAndAccruedExpenses	678000	USD
CY2013Q4	drio	Other Accounts Payable And Accrued Expenses OtherAccountsPayableAndAccruedExpenses	920000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1506000	USD
CY2014Q1	drio	Liability Related To Warrants LiabilityRelatedToWarrants	5775000	USD
CY2013Q4	drio	Liability Related To Warrants LiabilityRelatedToWarrants	2696000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19915000	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	20003000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-86000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4116000	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22879368	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20071816	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22879368	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20071816	shares
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2337000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	675000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7581000	USD
CY2014Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	725000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3375000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1904000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	854000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9483000	USD
CY2013Q1	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-2136000	USD
CY2014Q1	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	142000	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-1742000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-458000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-806000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2548000	USD
CY2014Q1	drio	Stock To Be Issued Upon Conversion Of Warrants Additional Issue StockToBeIssuedUponConversionOfWarrantsAdditionalIssue	1670216	shares
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	0	USD
	drio	Stock Issued During Period Value Issued For Services2 StockIssuedDuringPeriodValueIssuedForServices2	1000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	USD
	drio	Stock Issued During Period Value Issued For Services1 StockIssuedDuringPeriodValueIssuedForServices1		USD
	drio	Stock Issued During Period Value New Issues October And November2011 StockIssuedDuringPeriodValueNewIssuesOctoberAndNovember2011	481000	USD
	drio	Stock Issued During Period Value New Issues December2011 StockIssuedDuringPeriodValueNewIssuesDecember2011	86000	USD
CY2012	drio	Stock Issued During Period Value New Issues February And March2012 StockIssuedDuringPeriodValueNewIssuesFebruaryAndMarch2012	540000	USD
CY2012	drio	Stock And Warrant Issued During Period Value New Issues August2012 StockAndWarrantIssuedDuringPeriodValueNewIssuesAugust2012	498000	USD
CY2012	drio	Stock Issued During Period Value New Issues September And October2012 StockIssuedDuringPeriodValueNewIssuesSeptemberAndOctober2012	2384000	USD
CY2013	drio	Stock Issued During Period Value New Issues February And June2013 StockIssuedDuringPeriodValueNewIssuesFebruaryAndJune2013	996000	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	438000	USD
CY2013	drio	Warrant Issued During Period For Services Value March And May2013 WarrantIssuedDuringPeriodForServicesValueMarchAndMay2013	523000	USD
CY2013	drio	Stock Issued During Period Value New Issues April And May2013 StockIssuedDuringPeriodValueNewIssuesAprilAndMay2013	8987000	USD
CY2013	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	708000	USD
CY2014Q1	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	265000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20439000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
CY2014Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	564000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3213000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	509000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-5687000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-13931000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-385000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-1070000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	193000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	509000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	620000	shares
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8M23D
CY2014Q2	drio	Proceeds From Exercise Of Warrants ProceedsFromExerciseOfWarrants	256	shares
CY2014Q1	drio	Warrants Expiration Period WarrantsExpirationPeriod	P5Y
CY2013Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	259000	USD
CY2014Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	297000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3007000	USD
CY2013Q1	drio	Legal And Professional Fees LegalAndProfessionalFees	175000	USD
CY2014Q1	drio	Legal And Professional Fees LegalAndProfessionalFees	211000	USD
	drio	Legal And Professional Fees LegalAndProfessionalFees	1902000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1078000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	346000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3125000	USD
CY2013Q1	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	392000	USD
CY2014Q1	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	1449000	USD
CY2013Q1	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	1712000	USD
CY2014Q1	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	509000	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	5735000	USD
CY2013Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2014Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	448000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	706000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	117000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	198000	USD
	us-gaap	Depreciation Depreciation	1062000	USD
CY2013Q1	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	8000	USD
CY2014Q1	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	73000	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	519000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	128000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-51000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	535000	USD
CY2013Q1	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-2136000	USD
CY2014Q1	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	142000	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-1742000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	170000	USD
CY2013Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2014Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	98000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-972000	USD
CY2013Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	13000	USD
CY2014Q1	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	0	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	78000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	116000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2224000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-462000	USD
CY2013Q1	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	498000	USD
CY2013Q1	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised		USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	294000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	4000	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	424000	USD
CY2014Q1	drio	Stock Issued During Period Value New Issues February2014 StockIssuedDuringPeriodValueNewIssuesFebruary2014	1031000	USD
CY2013Q1	drio	Receivable On Account Of Shares ReceivableOnAccountOfShares	0	USD
CY2014Q1	drio	Receivable On Account Of Shares ReceivableOnAccountOfShares	67000	USD
	drio	Receivable On Account Of Shares ReceivableOnAccountOfShares	67000	USD
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22966389	shares
CY2014Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 56.7pt"> <div>NOTE 3:-</div> </td> <td style="TEXT-ALIGN: justify"> <div>UNAUDITED INTERIM FINANCIAL STATEMENTS</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The accompanying unaudited interim consolidated financial statements as of March 31, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of March 31, 2014, and the Company's consolidated results of operations and the Company's consolidated cash flows for the three months ended March 31, 2014. Results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1	drio	Stock Option Maximum Term StockOptionMaximumTerm	P10Y
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1124	USD
CY2013Q1	drio	Bank Charges BankCharges	4000	USD
CY2014Q1	drio	Bank Charges BankCharges	5000	USD
	drio	Bank Charges BankCharges	28000	USD
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11000	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-72000	USD
CY2013Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
CY2014Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	448000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	706000	USD
CY2014Q1	drio	Percentage Of Aggregate Of Weighted Average Prices Of Common Stock PercentageOfAggregateOfWeightedAveragePricesOfCommonStock	0.9	pure
CY2014Q1	drio	Percentage Of Common Shares Held By Affiliates PercentageOfCommonSharesHeldByAffiliates	0.0499	pure
CY2014Q1	drio	Increase In Limit Of Common Shares Held By Affiliates IncreaseInLimitOfCommonSharesHeldByAffiliates	0.0999	pure
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Trading Symbol TradingSymbol	DRIO
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	LabStyle Innovations Corp.
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001533998
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14808563000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21274831000	shares
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14808563	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21418439	shares

Files In Submission

Name	View Source	Status
0001144204-14-030461-index-headers.html	Edgar Link	pending
0001144204-14-030461-index.html	Edgar Link	pending
0001144204-14-030461.txt	Edgar Link	pending
0001144204-14-030461-xbrl.zip	Edgar Link	pending
drio-20140331.xml	Edgar Link	completed
drio-20140331.xsd	Edgar Link	pending
drio-20140331_cal.xml	Edgar Link	unprocessable
drio-20140331_def.xml	Edgar Link	unprocessable
drio-20140331_lab.xml	Edgar Link	unprocessable
drio-20140331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v376878_10q.htm	Edgar Link	pending
v376878_ex31-1.htm	Edgar Link	pending
v376878_ex31-2.htm	Edgar Link	pending
v376878_ex32-1.htm	Edgar Link	pending
v376878_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DRIO
DarioHealth Corp. Stock $drio

2014 Q1 Form 10-Q Financial Statement

#000114420414030461 Filed on May 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO DarioHealth Corp. Stock $drio

2014 Q1 Form 10-Q Financial Statement

#000114420414030461 Filed on May 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO
DarioHealth Corp. Stock $drio